INDIAGLYCO

India Glycols Share Price

₹1,143.00 +0.2 (0.02%)

19 Nov, 2024 17:58

SIP TrendupStart SIP in INDIAGLYCO

Start SIP

Performance

  • Low
  • ₹1,134
  • High
  • ₹1,179
  • 52 Week Low
  • ₹679
  • 52 Week High
  • ₹1,549
  • Open Price₹1,146
  • Previous Close₹1,143
  • Volume54,410

Investment Returns

  • Over 1 Month -17.2%
  • Over 3 Month -9.17%
  • Over 6 Month + 42.8%
  • Over 1 Year + 62.96%
SIP Lightning

Smart Investing Starts Here Start SIP with India Glycols for Steady Growth!

Invest Now

India Glycols Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 18.2
  • PEG Ratio
  • 0.9
  • Market Cap Cr
  • 3,539
  • P/B Ratio
  • 1.7
  • Average True Range
  • 61.13
  • EPS
  • 62.64
  • Dividend Yield
  • 0.7
  • MACD Signal
  • -30.74
  • RSI
  • 39.25
  • MFI
  • 56.19

India Glycols Financials

India Glycols Technicals

EMA & SMA

Current Price
₹1,143.00
+ 0.2 (0.02%)
pointer
  • stock-down_img
  • Bullish Moving Average 3
  • stock-up_img
  • Bearish Moving Average 13
  • 20 Day
  • ₹1,222.21
  • 50 Day
  • ₹1,245.94
  • 100 Day
  • ₹1,188.30
  • 200 Day
  • ₹1,070.17

Resistance and Support

1143.68 Pivot Speed
  • R3 1,207.07
  • R2 1,186.23
  • R1 1,164.52
  • S1 1,121.97
  • S2 1,101.13
  • S3 1,079.42

What's your outlook on India Glycols?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

India Glycols Ltd. is a leading manufacturer of specialty chemicals and ethylene glycol in India. The company produces a wide range of products, including antifreeze, solvents, and surfactants, serving diverse industries such as automotive, textiles, and personal care.

India Glycols (Nse) has an operating revenue of Rs. 3,760.20 Cr. on a trailing 12-month basis. An annual revenue growth of 24% is outstanding, Pre-tax margin of 6% is okay, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 35%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 14% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 60 which is a FAIR score but needs to improve its earnings, a RS Rating of 69 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 73 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

India Glycols Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-07 Quarterly Results
2024-07-29 Quarterly Results
2024-05-28 Audited Results & Final Dividend
2024-02-02 Quarterly Results
2023-11-03 Quarterly Results

India Glycols F&O

India Glycols Shareholding Pattern

61.01%
1.93%
2.9%
0%
26.78%
7.38%

About India Glycols

  • NSE Symbol
  • INDIAGLYCO
  • BSE Symbol
  • 500201
  • Chairman & Managing Director
  • Mr. U S Bhartia
  • ISIN
  • INE560A01015

Similar Stocks to India Glycols

India Glycols FAQs

India Glycols share price is ₹1,143 As on 19 November, 2024 | 17:44

The Market Cap of India Glycols is ₹3538.9 Cr As on 19 November, 2024 | 17:44

The P/E ratio of India Glycols is 18.2 As on 19 November, 2024 | 17:44

The PB ratio of India Glycols is 1.7 As on 19 November, 2024 | 17:44

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23